Actively Recruiting
Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
Led by Tanta University · Updated on 2026-05-14
126
Participants Needed
1
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective randomized double blinded study will be conducted to evaluate the effect of early pharmacologic intervention with calcitonin on the incidence or the severity of neuropathic pain after spinal cord injury
CONDITIONS
Official Title
Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older with spinal cord injury at any level and any degree of completeness in the early stage of trauma
You will not qualify if you...
- Current use of anticonvulsant medications
- Presence of neuropathic pain
- Previous allergic reaction to calcitonin
- Renal, hepatic, or cardiac dysfunction
- Neurological disorders
- Brain damage or major trauma to extremities or abdomen
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tanta University
Tanta, Gharbia Governorate, Egypt, 31527
Actively Recruiting
Research Team
O
Osama M Rehab, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here